HomeANW • FRA
Immuron Ltd
€0.060
Mar 28, 11:00:05 PM GMT+1 · EUR · FRA · Disclaimer
StockDE listed securityAU headquartered
Previous close
€0.057
Day range
€0.060 - €0.060
Year range
€0.032 - €0.11
Market cap
26.22M AUD
Avg Volume
5.25K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD)Dec 2023Y/Y change
Revenue
1.18M303.60%
Operating expense
1.72M49.58%
Net income
-1.04M-4.79%
Net profit margin
-88.0174.04%
Earnings per share
EBITDA
-925.42K0.81%
Effective tax rate
Total assets
Total liabilities
(AUD)Dec 2023Y/Y change
Cash and short-term investments
16.42M-14.23%
Total assets
19.88M-13.93%
Total liabilities
2.36M28.30%
Total equity
17.53M
Shares outstanding
227.80M
Price to book
0.71
Return on assets
-11.66%
Return on capital
-13.10%
Net change in cash
(AUD)Dec 2023Y/Y change
Net income
-1.04M-4.79%
Cash from operations
-1.00M-102.00%
Cash from investing
76.75K105.90%
Cash from financing
-11.58K-7.80%
Net change in cash
-973.15K46.46%
Free cash flow
-580.79K1.36%
About
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited. Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment. In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Founded
1994
Employees
6
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu